Kasukawa Yuji, Miyakoshi Naohisa, Ebina Toshihito, Hongo Michio, Ishikawa Yoshinori, Kudo Daisuke, Nozaka Koji, Shimada Yoichi
Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Akita Bone and Osteoporosis Network (A-BONE).
Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):140-145. doi: 10.11138/ccmbm/2017.14.1.140. Epub 2017 Oct 25.
The purpose of this retrospective clinical-based observational study was to evaluate the effects of teriparatide (TPTD) on clinical outcomes and radiologic findings of sacral insufficiency fractures (SIFs). Seven elderly women with SIFs received TPTD for at least 6 months. We evaluated the symptoms, pain, and radiological findings. At their initial clinic visit, 86% patients could not walk or sit. Computed tomography (CT) images revealed sacral wing fracture in 6 patients, and bone scintigram showed H-shaped uptake over the bilateral sacral wings in 1 patient. After the treatment, 5 patients could walk. Mean visual analog scale score was significantly lower after (12.9 mm) than before (87.4 mm) TPTD treatment (p < 0.0001). CT images revealed bone union (four patients) and sclerotic changes (three patients) at the fracture sites. Seven elderly women with SIFs had significant improvement in pain and demonstrated bone union or sclerotic changes at fracture sites by TPTD.
这项基于回顾性临床的观察性研究旨在评估特立帕肽(TPTD)对骶骨不全骨折(SIFs)临床结局和影像学表现的影响。7名患有SIFs的老年女性接受了至少6个月的TPTD治疗。我们评估了症状、疼痛和影像学表现。在初次门诊就诊时,86%的患者无法行走或坐下。计算机断层扫描(CT)图像显示6例患者有骶骨翼骨折,骨闪烁显像显示1例患者双侧骶骨翼呈H形摄取。治疗后,5例患者能够行走。平均视觉模拟量表评分在TPTD治疗后(12.9 mm)显著低于治疗前(87.4 mm)(p < 0.0001)。CT图像显示骨折部位有骨愈合(4例患者)和硬化改变(3例患者)。7名患有SIFs的老年女性疼痛有显著改善,且TPTD治疗使骨折部位出现骨愈合或硬化改变。